Literature DB >> 24920772

Vacuolating cytotoxin genotypes are strong markers of gastric cancer and duodenal ulcer-associated Helicobacter pylori strains: a matched case-control study.

Ameer A Memon1, Nawfal R Hussein2, Véronique Y Miendje Deyi3, Alain Burette4, John C Atherton2.   

Abstract

The Helicobacter pylori virulence gene, cagA, and active forms of the vacuolating cytotoxin gene, vacA, are major determinants of pathogenesis. However, previous studies linking these factors to disease risk have often included patients using aspirin/nonsteroidal anti-inflammatory agents (NSAIDs) or acid-suppressing drugs, both of which may confound results. Also, particularly for gastric cancer (GC), controls have often been of quite different ages. Here, we performed a careful study in a "clean" Belgian population with gastric cancer cases age and sex matched to 4 controls and with a parallel duodenal ulcer (DU) group. As in other populations, there was a close association between the presence of cagA and the vacA s1 genotype. For GC, associations were found for vacA s1-positive (P = 0.01, odds ratio [OR], 9.37; 95% confidence interval [CI], 1.16 to 201.89), i1-positive (P = 0.003; OR, 12.08; 95% CI, 1.50 to 259.64), and cagA-positive status (P < 0.05; OR, infinity; 95% CI, 0.76 to infinity). For DU, associations were found with vacA s1 (P = 0.002; OR, 6.04; 95% CI, 1.52 to 27.87) and i1 (P = 0.004; OR, 4.35; 95% CI, 1.36 to 14.78) status but not with cagA status. Neither condition showed independent associations with the vacA m1 allele or with more biologically active forms of cagA with longer 3' variable regions. In this Belgian population, the best markers of gastric cancer- and duodenal ulcer-associated strains are the vacA s1 and i1 genotypes. This fits with experimental data showing that the s and i regions are the key determinants of vacuolating cytotoxin activity.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24920772      PMCID: PMC4136171          DOI: 10.1128/JCM.00551-14

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  30 in total

1.  Allelic diversity of the Helicobacter pylori vacuolating cytotoxin gene in South Africa: rarity of the vacA s1a genotype and natural occurrence of an s2/m1 allele.

Authors:  D P Letley; A Lastovica; J A Louw; C J Hawkey; J C Atherton
Journal:  J Clin Microbiol       Date:  1999-04       Impact factor: 5.948

2.  Simple method for determination of the number of Helicobacter pylori CagA variable-region EPIYA tyrosine phosphorylation motifs by PCR.

Authors:  Richard H Argent; Youli Zhang; John C Atherton
Journal:  J Clin Microbiol       Date:  2005-02       Impact factor: 5.948

3.  Antibody against Helicobacter pylori CagA and VacA and the risk for gastric cancer.

Authors:  Y Yamaoka; T Kodama; K Kashima; D Y Graham
Journal:  J Clin Pathol       Date:  1999-03       Impact factor: 3.411

4.  No correlation of babA2 with vacA and cagA genotypes of Helicobacter pylori and grading of gastritis from peptic ulcer disease patients in Brazil.

Authors:  Rejane Mattar; Anibal Ferreira dos Santos; Jaime Natan Eisig; Tomas Navarro Rodrigues; Fernando Marcuz Silva; Renato Micelli Lupinacci; Kiyoshi Iriya; Flair José Carrilho
Journal:  Helicobacter       Date:  2005-12       Impact factor: 5.753

5.  Association of H pylori cagA and vacA genotypes and IL-8 gene polymorphisms with clinical outcome of infection in Iranian patients with gastrointestinal diseases.

Authors:  Eskandar Kamali-Sarvestani; Abdulah Bazargani; Malihe Masoudian; Kamran Lankarani; Ali-Reza Taghavi; Mehdi Saberifiroozi
Journal:  World J Gastroenterol       Date:  2006-08-28       Impact factor: 5.742

6.  Analysis of Helicobacter pylori vacA and cagA genotypes and serum antibody profile in benign and malignant gastroduodenal diseases.

Authors:  D Basso; F Navaglia; L Brigato; M G Piva; A Toma; E Greco; F Di Mario; F Galeotti; G Roveroni; A Corsini; M Plebani
Journal:  Gut       Date:  1998-08       Impact factor: 23.059

7.  Diversity of Helicobacter pylori vacA and cagA genes and relationship to VacA and CagA protein expression, cytotoxin production, and associated diseases.

Authors:  J Rudi; C Kolb; M Maiwald; D Kuck; A Sieg; P R Galle; W Stremmel
Journal:  J Clin Microbiol       Date:  1998-04       Impact factor: 5.948

8.  Functional association between the Helicobacter pylori virulence factors VacA and CagA.

Authors:  Richard H Argent; Rachael J Thomas; Darren P Letley; Michael G Rittig; Kim R Hardie; John C Atherton
Journal:  J Med Microbiol       Date:  2008-02       Impact factor: 2.472

9.  Relationship of vacA genotypes of Helicobacter pylori to cagA status, cytotoxin production, and clinical outcome.

Authors:  Y Yamaoka; T Kodama; M Kita; J Imanishi; K Kashima; D Y Graham
Journal:  Helicobacter       Date:  1998-12       Impact factor: 5.753

10.  A new Helicobacter pylori vacuolating cytotoxin determinant, the intermediate region, is associated with gastric cancer.

Authors:  Joanne L Rhead; Darren P Letley; Marjan Mohammadi; Nawfal Hussein; Mohammad A Mohagheghi; Mahmoud Eshagh Hosseini; John C Atherton
Journal:  Gastroenterology       Date:  2007-07-03       Impact factor: 22.682

View more
  31 in total

Review 1.  Pathogenesis of Helicobacter pylori Infection.

Authors:  Dionyssios N Sgouras; Tran Thi Huyen Trang; Yoshio Yamaoka
Journal:  Helicobacter       Date:  2015-09       Impact factor: 5.753

2.  Reply to "Helicobacter pylori vacA as marker for gastric cancer and gastroduodenal diseases: one but not the only factor".

Authors:  Ameer A Memon; John C Atherton
Journal:  J Clin Microbiol       Date:  2014-12       Impact factor: 5.948

3.  Helicobacter pylori vacA as marker for gastric cancer and gastroduodenal diseases: one but not the only factor.

Authors:  Amin Talebi Bezmin Abadi; Yeong Yeh Lee
Journal:  J Clin Microbiol       Date:  2014-12       Impact factor: 5.948

Review 4.  Helicobacter pylori in gastric carcinogenesis.

Authors:  Hyo Jun Ahn; Dong Soo Lee
Journal:  World J Gastrointest Oncol       Date:  2015-12-15

5.  Structural organization of membrane-inserted hexamers formed by Helicobacter pylori VacA toxin.

Authors:  Tasia M Pyburn; Nora J Foegeding; Christian González-Rivera; Nathan A McDonald; Kathleen L Gould; Timothy L Cover; Melanie D Ohi
Journal:  Mol Microbiol       Date:  2016-07-08       Impact factor: 3.501

6.  Cryo-EM Analysis Reveals Structural Basis of Helicobacter pylori VacA Toxin Oligomerization.

Authors:  Min Su; Amanda L Erwin; Anne M Campbell; Tasia M Pyburn; Lauren E Salay; Jessica L Hanks; D Borden Lacy; David L Akey; Timothy L Cover; Melanie D Ohi
Journal:  J Mol Biol       Date:  2019-04-05       Impact factor: 5.469

7.  Helicobacter pylori vacA i region polymorphism but not babA2 status associated to gastric cancer risk in northwestern Iran.

Authors:  Batool Mottaghi; Reza Safaralizadeh; Morteza Bonyadi; Saeid Latifi-Navid; Mohammad Hossein Somi
Journal:  Clin Exp Med       Date:  2014-12-04       Impact factor: 3.984

8.  Helicobacter pylori vacuolating cytotoxin and gastric cancer risk: reconsidered.

Authors:  Muhammad Miftahussurur; Yoshio Yamaoka; David Y Graham
Journal:  Transl Cancer Res       Date:  2016-09       Impact factor: 1.241

9.  Helicobacter pullorum isolated from fresh chicken meat: antibiotic resistance and genomic traits of an emerging foodborne pathogen.

Authors:  Vítor Borges; Andrea Santos; Cristina Belo Correia; Margarida Saraiva; Armelle Ménard; Luís Vieira; Daniel A Sampaio; Miguel Pinheiro; João Paulo Gomes; Mónica Oleastro
Journal:  Appl Environ Microbiol       Date:  2015-09-18       Impact factor: 4.792

10.  New Biology to New Treatment of Helicobacter pylori-Induced Gastric Cancer.

Authors:  Richard M Peek
Journal:  Dig Dis       Date:  2016-06-22       Impact factor: 2.404

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.